Liposomal technology
Liposomes...
Liposomes are tiny delivery systems composed of a phospholipid bilayer, structurally similar to the membranes of human cells.¹
Thanks to this unique structure, liposomes can encapsulate and protect active ingredients, helping to deliver them more efficiently to various parts of the body.
Enhanced Active Ingredient Stability
The liposomal coating helps protect active ingredients from stomach acid, digestive enzymes, and oxidative stress, supporting their stability and integrity throughout the digestive system.²
Enhanced Absorption and Bioavailability
The cell membrane-like structure of liposomes supports the more efficient absorption of active ingredients and facilitates their delivery into cells.⁴˒⁵
Enhanced Solubility and Distribution
Many plant-derived active ingredients have poor water solubility. Liposomal delivery helps improve their dispersion within the gastrointestinal tract, supporting more efficient absorption and utilization.³
Effective Utilization at Lower Doses
Thanks to improved absorption, lower amounts of active ingredients may be sufficient for optimal utilization by the body, potentially helping to reduce the risk of side effects.⁶
BENEFITS OF LIPOSOMAL TECHNOLOGY FOR PLANT EXTRACTS.
Why We Chose Liposomal Technology?
Liposomal technology is a modern active ingredient delivery system designed to mimic natural cell structures, supporting improved bioavailability and more efficient utilization of active compounds.
Bibliography:
-
Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022 May 13;8(5):e09394. doi:10.1016/j.heliyon.2022.e09394. PMID:35600452; PMCID:PMC9118483. https://pmc.ncbi.nlm.nih.gov/articles/PMC9118483/
-
Shade CW. Liposomes as advanced delivery systems for nutraceuticals. Integr Med (Encinitas). 2016 Mar;15(1):33–36. PMID:27053934; PMCID:PMC4818067. https://pmc.ncbi.nlm.nih.gov/articles/PMC4818067/
-
Lee MK. Liposomes for enhanced bioavailability of water-insoluble drugs: in vivo evidence and recent approaches. Pharmaceutics. 2020 Mar 13;12(3):264. doi:10.3390/pharmaceutics12030264. PMID:32183185; PMCID:PMC7151102. https://pmc.ncbi.nlm.nih.gov/articles/PMC7151102/
-
Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021 May 15;601:120571. doi:10.1016/j.ijpharm.2021.120571. PMID:33812967. https://pubmed.ncbi.nlm.nih.gov/33812967/
-
Cheng X, Yan H, Pang S, Ya M, Qiu F, Qin P, Zeng C, Lu Y. Liposomes as multifunctional nano-carriers for medicinal natural products. Front Chem. 2022 Aug 8;10:963004. doi:10.3389/fchem.2022.963004. PMID:36003616; PMCID:PMC9393238. https://pmc.ncbi.nlm.nih.gov/articles/PMC9393238/
-
Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015 Dec 1;6:286. doi:10.3389/fphar.2015.00286. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2015.00286/full